Oxford BioMedica warns revenue will be hit by AstraZeneca jab uncertainty
[ad_1] Oxford BioMedica warned that uncertainty over the future of its contract to manufacture AstraZeneca’s Covid-19 vaccine would cause revenue to decline this year, sending its share price down 6…